Delcasertib (KAI-9803) hydrochloride is a potent and selective δ-protein kinase C ( δPKC ) inhibitor. Delcasertib (KAI-9803) hydrochloride could ameliorate injury associated with ischemia and reperfusion in animal models of acute myocardial infarction (MIAppearance:SolidIC50& Target:δPKCIn Vitro:Delcasertib (KAI-9803) is composed of a selective δ-protein kinase C (δPKC) inhibitor peptide derived from the δV1-1 portion of δPKC (termed “cargo peptide”), conjugated reversibly to the cell-penetrating peptide 11-amino acid, arginine-rich sequence of tIn Vivo:Delcasertib (KAI-9803, a single intraperitoneal injection) in mice results in the selective inhibition of PKC translocation in the liver, kidney, lung, heart, and brain. Delcasertib (KAI-9803) administration at the end of ischemia has been found to rBiological Activity:Delcasertib (KAI-9803) hydrochloride is a potent and selective δ-protein kinase C ( δPKC ) inhibitor. Delcasertib (KAI-9803) hydrochloride could ameliorate injury associated with ischemia and reperfusion in animal models of acute myocardial infarction (MI. Specification: 0.98 Molecular Formula: C120H200ClN45O34S2 Molecular Weight: 2916.74
- UPC:
- 51432006
- Condition:
- New
- Availability:
- 8-12 weeks
- Weight:
- 1.09 Ounces
- HazmatClass:
- No
- WeightUOM:
- LB
- MPN:
- D659093-10mg
- Product Size:
- 10mg
